Skip to content

Study of unani medicine in management of problems of females before menses

Efficacy of Sumbul-ut-teeb in the management of Premenstrual Syndrome: A randomized controlled study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011912
Enrollment
60
Registered
2018-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Premenstrual Syndrome

Interventions

Intervention1: Fine powder of Sumbul-ut-teeb: 4gm of Fine powder of Sumbul-ut-teeb was given in capsule form daily in two divided doses, 15 days prior to expected date of menstruation for two consecut

Sponsors

National institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients age within the range of 18 to 45 years Patients with regular cycle and a cycle length of 21-35 days; presenting with signs and symptoms of premenstrual tension syndrome.

Exclusion criteria

Exclusion criteria: Patients with irregular menstrual cycle and any organic pelvic pathology. Patients on hormonal replacement therapy, oral contraceptive, undergone hysterectomy. Patients with known systemic and metabolic diseases. Diagnosed cases of psychiatric disorder. Lactating mothers.

Design outcomes

Primary

MeasureTime frame
Premenstrual tension scale (PMTS) VAS-scale Timepoint: Before and after treatment

Secondary

MeasureTime frame
More than 1 of the following symptoms. Depression, irritability, anxiety, angry outburst, confusion, social withdrawal, breast tenderness, abdominal bloating, headache, swelling of extremities. Timepoint: During treatment: every month after menstruation for two cycles. After treatment: One follow-up after menstruation.

Countries

India

Contacts

Public ContactDr Muzafar Din Ahmad Bhat

National Institute of Unani Medicine

drmuzaffar79@gmail.com9590366192

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026